Key Statistics for Acute Lymphocytic Leukemia (ALL)

The American Cancer Society’s estimates for acute lymphocytic leukemia (ALL) in the United States for 2019 (including both children and adults) are:

  • About 5,930 new cases of ALL (3,280 in males and 2,650 in females)
  • About 1,500 deaths from ALL (850 in males and 650 in females)

The risk for developing ALL is highest in children younger than 5 years of age. The risk then declines slowly until the mid-20s, and begins to rise again slowly after age 50. Overall, about 4 of every 10 cases of ALL are in adults.

ALL is not a common cancer, accounting for less than half of 1% of all cancers in the United States. The average person’s lifetime risk of getting ALL is about 1 in 1000. The risk is slightly higher in males than in females, and higher in whites than in African Americans.

Most cases of ALL occur in children, but most deaths from ALL (about 4 out of 5) occur in adults. Children may do better than adults because of differences in the nature of childhood and adult ALL, differences in treatment (children’s bodies can often handle aggressive treatment better than adult’s), or some combination of these.

Visit the American Cancer Society’s Cancer Statistics Center for more key statistics.

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

American Cancer Society. Cancer Facts & Figures 2019. Atlanta, Ga: American Cancer Society; 2019.

Appelbaum FR. Chapter 98: Acute Leukemias in Adults. In: Niederhuber JE, Armitage JO, Dorshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa. Elsevier: 2014.

National Cancer Institute. SEER Cancer Stat Facts: Acute Lymphocytic Leukemia (ALL). Accessed at on July 18, 2018.

Last Medical Review: October 17, 2018 Last Revised: January 8, 2019

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.